The level of expression of voltage-gated calcium channels at the plasma membrane is a key regulator of calcium homeostasis in excitable cells, and of downstream effects such as calcium-dependent transcription 1,2 . Members of the high voltage-activated (HVA) calcium channel family are heteromultimeric protein complexes that contain a pore-forming α 1 subunit that defines the channel subtype, plus ancillary α 2 -δ and β subunits that not only alter the function of the α 1 subunit but also regulate the trafficking of the channel complex to the plasma membrane 3-8 . The mammalian genome encodes four different types of Cavβ subunit that have distinct spatial and temporal expression patterns [4] [5] [6] . With the exception of Cavβ 2a , these subunits are cytoplasmic proteins that physically bind to a region in the α 1 subunit domain I-II linker that is highly conserved among all HVA calcium channels and is termed the alpha interaction domain (AID) 7 . Crystal structure data show that the Cavβ subunit contains interacting SH3 and guanylate kinase domains, with the latter participating in high-affinity binding to the AID region [8] [9] [10] . The physiological consequences of this interaction are underscored by gene knockout studies showing that deletion of the Cavβ 1a or Cavβ 2a subunits causes embryonic lethality 11, 12 and by findings that a premature stop mutation in Cavβ 4 causes an epileptic phenotype in mice 13 .
The level of expression of voltage-gated calcium channels at the plasma membrane is a key regulator of calcium homeostasis in excitable cells, and of downstream effects such as calcium-dependent transcription 1, 2 . Members of the high voltage-activated (HVA) calcium channel family are heteromultimeric protein complexes that contain a pore-forming α 1 subunit that defines the channel subtype, plus ancillary α 2 -δ and β subunits that not only alter the function of the α 1 subunit but also regulate the trafficking of the channel complex to the plasma membrane [3] [4] [5] [6] [7] [8] . The mammalian genome encodes four different types of Cavβ subunit that have distinct spatial and temporal expression patterns [4] [5] [6] . With the exception of Cavβ 2a , these subunits are cytoplasmic proteins that physically bind to a region in the α 1 subunit domain I-II linker that is highly conserved among all HVA calcium channels and is termed the alpha interaction domain (AID) 7 . Crystal structure data show that the Cavβ subunit contains interacting SH3 and guanylate kinase domains, with the latter participating in high-affinity binding to the AID region [8] [9] [10] . The physiological consequences of this interaction are underscored by gene knockout studies showing that deletion of the Cavβ 1a or Cavβ 2a subunits causes embryonic lethality 11, 12 and by findings that a premature stop mutation in Cavβ 4 causes an epileptic phenotype in mice 13 .
It has been suggested that the Cavβ subunit masks an endoplasmic reticulum retention signal on the Cav2.1 α 1 subunit 14 , thereby leading to increased cell surface expression of P/Q-type channels. However, no specific endoplasmic reticulum retention motif in the AID and surrounding regions of the α 1 subunit has been identified, and removing the AID motif in the I-II linker of Cav2.1 does not increase current amplitude in the absence of Cavβ (ref. 15) . Moreover, it is not clear whether different HVA calcium channel isoforms share common retention motifs. Here we show that Cav1.2 (L-type) calcium channels contain an endoplasmic reticulum retention motif in the proximal C-terminal region, and we provide evidence that the Cavβ subunit has a role in regulating proteasomal degradation of these channels. Our data show that the Cavβ subunit acts as a molecular switch that prevents the ubiquitination of the channels and their targeting to the ERAD complex and thereby regulates their expression at the plasma membrane.
RESULTS
Cavb regulates endoplasmic reticulum retention of Cav1. 2 We first performed an ELISA assay involving a Cav1.2 channel construct tagged with an extracellular hemagglutinin (HA) epitope (Fig. 1a) . We compared immunoluminescence between permeabilized and nonpermeabilized cells, which allowed us to quantify the relative proportion of Cav1.2 channels that were inserted into the plasma membrane. Coexpression with the Cavβ 1b or Cavβ 2a subunit mediated a significant increase in the fraction of Cav1.2 channels at the cell surface ( Fig. 1a and data not shown). This was confirmed by HA-immunoreactivity of nonpermeabilized cells (Fig. 1b) and surface biotinylation experiments (Fig. 1c) . Nonetheless, channel targeting to the plasma membrane remained incomplete even in the presence of Cavβ 1b , indicating that there was a substantial pool of Cav1.2 channels in cytoplasmic compartments ( Fig. 1a and Supplementary Fig. 1) . Coexpression of the Cavβ 1b subunit 1 7 4 VOLUME 14 | NUMBER 2 | FEBRUARY 2011 nature neurOSCIenCe a r t I C l e S also increased the total pool of HA-Cav1.2 channels (Fig. 1d,e) , indicating that Cavβ either promotes the expression of Cav1.2 or prevents protein degradation. The Cavβ subunit-mediated increase in total Cav1.2 expression and the enhanced membrane trafficking give rise to a substantial increase in channel protein at the cell surface (Fig. 1b,e) , thereby accounting for the known effect of Cavβ subunits on whole-cell current densities.
The reduced surface expression of Cav1.2 in the absence of the Cavβ subunit could in principle be due to retention of the α 1 subunit in the endoplasmic reticulum. To identify putative retention motifs in the channel sequence, we created a series of CD4 constructs fused to the various intracellular regions of Cav1.2 (and for comparison Cav2.2 N-type) channels (Fig. 2a) . These constructs were expressed in tsA-201 cells and their expression monitored initially by immunostaining and confocal microscopy. In a control experiment, coexpression of the domain I-II linker CD4 construct resulted in the translocation of the Cavβ 1b subunit from the cytoplasm to the plasma membrane (Fig. 2b) , indicating that the ability of the I-II linker region to interact with the Cavβ subunit was preserved in the CD4 fusion construct. By contrast, a CD4 construct of the domain I-II linker of Cav3.2 T-type channels (which do not interact with Cavβ) did not mediate such translocation (Fig. 2b) , nor did other regions of the Cav1.2 channels that cannot bind Cavβ (Supplementary Fig. 2a) . Next, we examined the surface expression of the entire set of CD4 constructs using immunoluminometry. We used the expression of a a r t I C l e S positive control construct for sorting (CD4-AA) for normalization, and data were compared to the surface expression levels of a 'retention control' (CD4-KK) 16, 17 . The N terminus, domain I-II linker, domain II-III linker and domain III-IV linker regions of the channel were trafficked to the plasma membrane as effectively as CD4-AA (Fig. 2c,d ).
Although coexpression of the Cavβ 1b or Cavβ 2a subunits seemed to mediate a small increase in the membrane trafficking of the domain I-II linker region, this was not statistically significant, and was eclipsed in magnitude by the effect of Cavβ on the membrane expression of full-length Cav1.2 ( Fig. 1) . These data indicate that the Cav1.2 domain I-II linker does not contain an endoplasmic reticulum retention signal ( Fig. 2c,d and Supplementary Fig. 2b ). By contrast, CD4 constructs corresponding to either the entire C terminus or the proximal third of this region showed reduced surface expression (Fig. 2c) .
Within the proximal C terminus region of Cav1.2, two distinct subregions showed endoplasmic reticulum retention. We obtained qualitatively similar results with the Cav2.2 C terminus ( Fig. 2d) with the exception that it contained only one endoplasmic reticulum retention motif; nonetheless, this indicates that the retention mechanism may be conserved among N-type and L-type channels ( Supplementary  Fig. 3 ). Retention of the Cav1.2 or Cav2.2 C terminus in the endoplasmic reticulum could not be reversed upon coexpression of the Cavβ 1b or Cavβ 2a subunit (Fig. 2c,d) , consistent with the notion that the Cavβ subunit does not bind to this region of the channel. These findings contrast with results obtained with Cav2.1 constructs in which the I-II linker rather than the C terminus was retained, and Cavβ subunit coexpression counteracted this endoplasmic reticulum retention ( Supplementary Fig. 4 ), in agreement with previous suggestions that Cavβ directly occludes the Cav2.1 retention motif 14 . Together, our data indicate that calcium channels can be subject to at least two distinct mechanisms that regulate export from the endoplasmic reticulum.
Cavb-free channels are targeted to the proteasome Although the idea that the Cavβ subunit facilitates channel export from the endoplasmic reticulum fits with the observed increase in cell surface expression of the channels, it is unlikely to account for the observed increase in total Cav1.2 protein (Fig. 1e) . One possibility is that the Cavβ subunit reduces channel turnover and targeting to endocytic compartments. However, in the absence of Cavβ there was no colocalization of HA-Cav1.2 with markers for early or late endosomes or with LysoTracker, which suggests that the reduced membrane expression observed in the absence of Cavβ was not mediated by enhanced internalization of Cavβ-free channels from the plasma membrane ( Supplementary Fig. 5 ). Alternatively, the Cavβ subunit might prevent channel degradation in the proteasome. To determine whether Cav1.2 channels were targeted to the proteasome in the absence of the Cavβ subunit, we examined the effect of the proteasome inhibitor MG132 under various transfection conditions (Fig. 3) . In cells expressing HA-Cav1.2 alone, MG132 treatment markedly increased plasma membrane expression of the channel ( Fig. 3a) and decreased the effect of Cavβ on HA-Cav1.2 surface expression from 2.71 ± 0.05-fold to 1.59 ± 0.015-fold (n = 6, **P < 0.01; see also Supplementary Fig. 6 ). Furthermore, MG132 increased total Cav1.2 channel protein when expressed alone or with the Cavα 2 -δ subunit, but not in the presence of Cavβ (Fig. 3b,c) . Analysis of the subcellular localization of HA-Cav1.2 showed that the channel alone did not colocalize with the membrane marker construct CD4-AA, whereas membrane colocalization was increased upon either coexpression of the Cavβ subunit or treatment with MG132 ( Fig. 4a-d) . Conversely, colocalization with a marker of the endoplasmic reticulum and perinuclear region (CD4-KK) was decreased (Supplementary Fig. 6 ).
Together, our results indicate that the Cavβ subunit stabilizes Cav1.2 channels and increases total Cav1.2 protein by preventing proteasomal degradation of the channels. Furthermore, our data suggest that blocking the proteasomal degradation pathway leads to cell surface targeting of Cav1.2 channels in the absence of Cavβ. Ubiquitinated Cav1.2 channels enter the ERAD complex Before proteasomal degradation, misfolded and unassembled membrane proteins are recognized and retrotranslocated into the cytosol where they pass though the 'quality control' system, ERAD. A protein complex that includes derlin-1 and p97 is responsible for recognizing misfolded proteins in yeast and for protein degradation mediated by viruses in host cells, and has been linked to the degradation of cystic fibrosis transmembrane conductance regulator (CFTR) channel mutants in mammalian cells [18] [19] [20] [21] . To determine whether Cav1.2 channels use a similar degradation pathway, we examined the ability of Cav1.2 channels to associate with these ERAD signaling proteins. Both derlin-1 and p97 could be detected by western blot analysis in tsA-201 cell lysate (not shown) and were found to co-immunoprecipitate with recombinant and native Cav1.2 channels (Fig. 4e) . Coexpression of Cavβ subunits in tsA-201 cells significantly reduced the co-immunopreciptation of derlin-1 and p97 with the channel (Fig. 4f,g ) when the data were normalized to total Cav1.2 channel expression. However, the association of derlin-1 and p97 with the channel was not completely eliminated in the presence of Cavβ. This could be due to one of two mechanisms. First, the Cavβ subunit may incompletely prevent the association of these proteins with a given channel. Alternatively (and consistent with the observations in Supplementary Fig. 1 a r t I C l e S even upon Cavβ subunit coexpression, there could be a pool of Cavβ-free channels that are associated with derlin-1 and p97. If so, treatment of the cells with MG132 should increase the pool of Cavβ-free channels and thus the overall fraction of channels that are associated with derlin-1 and p97, and this seems to be the case (Fig. 4e-g ).
Collectively, these data suggest that the Cavβ subunit acts as a gatekeeper for entry of Cav1.2 channels into the ERAD complex.
In the ERAD complex, misfolded and misassembled proteins can also be subject to ubiquitination in the endoplasmic reticulum 22, 23 which normally precedes the initiation of the proteasome pathway. Indeed, p97 is thought primarily to bind to ubiquitinated proteins. We therefore investigated the ubiquitination of HACav1.2 channels in the absence and presence of Cavβ subunits in tsA-201 cells. We blocked channel degradation with MG132, a r t I C l e S immunoprecipitated Cav1.2 channels with an HA antibody and analyzed immunoprecipitates by western blots using specific ubiquitin antibodies. Western blots of tsA-201 cell lysates expressing HA-Cav1.2 in the absence of Cavβ revealed high molecular weight bands that were also immunoreactive for ubiquitin (Fig. 5a) . Ubiquitin immunoreactivity was reduced upon coexpression of the Cavβ 1b subunit (Fig. 5b) , despite the fact that there was a large increase in total Cav1.2 protein (Fig. 1e) . Reminiscent of our findings with derlin-1 and p97, the Cavβ subunit did not completely prevent ubiquitination, again consistent with the existence of a fraction of Cavβ-free channels. Ubiquitination was also observed when cells were transfected with Hisubiquitin (Supplementary Fig. 7a ). The Cavβ 2a subunit was equally effective at preventing ubiquitination of the Cav1.2 channel, as shown by western blot even at extended film exposures (Supplementary Fig. 7b ). Unlike Cav1.2 channels, there was little ubiquitination of Cav2.1 in the absence of the Cavβ subunit (Supplementary Fig. 7c ), consistent with the idea that Cavβ regulates Cav2.1 channel expression by a different mechanism (Supplementary Fig. 4) . We also examined the ubiquitination of a mutant Cav1.2 calcium channel construct that cannot associate with the Cavβ subunit (HACav1.2 W440A ) 24, 25 . The mutant channel showed robust ubiquitination irrespective of the coexpression of Cavβ 1b (Fig. 5c) , indicating that the effect of Cavβ on the ubiquitination of wild-type Cav1.2 is due to its binding interaction with the channel, rather than simply its presence in the cell. Finally, we examined the ubiquitination of native Cav1.2 channels. In the neuronal cell line CAD, a population of endogenous Cav1.2 channels was ubiquitinated, and ubiquitinated channels accumulated when we blocked proteasomal degradation (Fig. 5d) . Native channels in rat hippocampal neurons also showed tonic ubiquitination (Fig. 5e) . Together, our data support a mechanism in which the Cavβ subunit antagonizes the ubiquitination of Cav1.2 channels.
RFP2 mediates ubiquitination of Cav1.2
Ubiquitination of target proteins typically involves the transfer of ubiquitin from an E2 ubiquitin conjugating enzyme by an E3 ubiquitin ligase. The mammalian genome expresses more than 600 E3 ubiquitin ligases with different localizations and functions 26 ; among these, ligases such as Nedd4 have been implicated in the internalization of channels such as ENaC and ClC-5 whereas ligases associated with the ERAD complex have been linked to proteasomal degradation of channels such as CFTR 23 . Consistent with involvement of the ERAD complex in regulation of Cav1.2, we found no association of Nedd4 with the L-type channel (not shown). We then knocked down a subset of canonical endoplasmic reticulum-localized ubiquitin ligases using short hairpin RNAs (shRNAs) and examined the ubiquitination of Cav1.2 channels. Knockdown of RFP2, an E3 ubiquitin ligase 27 , resulted in a marked reduction in Cav1.2 channel ubiquitination, whereas knockdown of the Hrd1 or gp78 ligases (Fig. 6a-c) or of MARCH6 (data not shown) did not significantly reduce ubiquitination of the channel. We then tested whether RFP2 could associate with Cav1.2 channels. RFP2 co-immunoprecipitated with endogenous Cav1.2 channels in CAD cells (Fig. 6d) . Similarly, RFP2 and native Cav1.2 channels could be co-immunoprecipitated from rat brain homogenate (Fig. 6e) . Finally, YFP-tagged RFP2 could be co-immunoprecipitated from tsA-201 cells (Fig. 6f) . These results indicate that RFP2 can associate with Cav1.2 channels. To further implicate RFP2, we a r t I C l e S examined the effect of either wild-type RFP2 (WT-RFP2; Fig. 6g ) or dominant negative RFP2 (DN-RFP2; Fig. 6h ) on the degree of ubiquitination of Cav1.2 channels in tsA-201 cells. Expression of the WT-RFP2 construct mediated a small (22%) increase in Cav1.2 ubiquitination. Conversely, the extent of ubiquitination observed in the presence of the DN-RFP2 construct (Fig. 6h) was reduced by 52% relative to control, which confirms that the RFP2 ligase is involved in the ubiquitination of the Cav1.2 channel.
To determine the functional consequences of RFP2-mediated ubiquitination, we first examined the effects of the WT-and DN-RFP2 constructs on barium current densities in CAD cells (Fig. 7a) . Coexpression of DN-RFP2 resulted in a significant increase in wholecell current densities from 2.39 ± 0.22 pA pF −1 to 5.39 ± 0.55 pA pF −1 (P < 0.001), consistent with the biochemical data (Figs. 5d and 6h) . Coexpression of WT-RFP2 had no effect (data not shown), which indicates that there was sufficient endogenous RFP2 activity (Fig. 5d) . As CAD cells do not express a pure population of L-type currents, we carried out a series of analogous experiments in tsA-201 cells that were transfected with Cav1.2 (+Cavα 2 -δ) without a Cavβ subunit. We observed small barium currents (current density = 7.83 ± 1.15 pA pF −1 , n = 47) in the absence of Cavβ, as reported 28 . Coexpression of DN-RFP2 increased Cav1.2 peak current density to 17.16 ± 2.56 pA pF −1 (n = 42, P = 0.001) which fits with the biochemical analysis of Figure 1c . Together, these data show that interfering with RFP2-mediated ubiquitination of Cav1.2 channels increases the functional expression of these channels in the cell membrane.
We then examined the role of RFP2 in cultured rat hippocampal neurons. Neurons were transfected with HA-Cav1.2 with or without cotransfection of WT-or DN-RFP2 ligase. Live cells were incubated with HA antibody without permeabilization before fixation, allowing us to analyze the distribution of Cav1.2 channels on the cell surface ( Fig. 7b-d) . Expression of HA-Cav1.2 channels resulted in the appearance of discrete puncta along axonal and dendritic processes (Fig. 7b,c) , consistent with the association of a fraction of the expressed channels with endogenous Cavβ subunits. In cells that coexpressed DN-RFP2 (Fig. 7d) there was a statistically significant increase in the numbers of HA-Cav1.2 puncta per µm (from 2.25 ± 0.24 to 5.54 ± 0.41, n = 22 and n = 26, respectively; P < 0.01) and in overall HA-Cav1.2 cell surface expression (from 18.05 ± 1.42 to 32.57 ± 1.13 pixel intensity units per surface area, n = 39 and n = 90, respectively; P < 0.01) compared with cells expressing the WT-RFP2 construct. This fits with a mechanism by which DN-RFP2 results in the targeting of the excess HA-Cav1.2 channels that are not associated with endogenous Cavβ subunits to the cell surface. Collectively, our data are consistent with the idea that RFP2 has an active role in regulating L-type channel membrane trafficking in neurons. Qualitatively similar results were obtained when we competitively uncoupled Cavβ subunits from Cav1.2 by overexpressing a construct corresponding to the I-II linker of the channel ( Supplementary  Fig. 8) . Overall, several lines of evidence implicate RFP2 ubiquitin ligase as a regulator of Cav1.2 channel function and expression in both heterologous expression systems and native tissues.
DISCUSSION
The role of the Cavβ subunit in enhancing cell surface levels of HVA channels is well established, but how this regulation occurs at the molecular level has remained largely unknown. Here, we provide insights into the cell signaling pathways that regulate the plasma membrane density of Cav1.2 L-type channels. Our data show that the Cavβ subunit controls a sorting step in the endoplasmic reticulum that diverts channels from the ERAD complex to the cell surface (Supplementary Fig. 9 ). This may involve multiple Cavβ subunitdependent steps, including interference with an endoplasmic reticulum retention motif in the C terminus, occlusion of ubiquitination sites and perhaps preventing the association of the channel with ubiquitin ligase(s).
Our data indicate that different types of HVA channels have evolved different mechanisms by which the Cavβ subunit regulates their export from the endoplasmic reticulum. First, compared with Cav1.2, Cav2.1 channels do not appear to undergo much ubiquitination in the absence of the Cavβ subunit. Furthermore, in contrast with Cav1.2 and Cav2.2 channels, retention of Cav2.1 in the endoplasmic reticulum seems to be mediated by the domain I-II linker rather than the C-terminal region. This suggests that Cav2.1 channels use an endoplasmic reticulum export pathway that is different from that used by L-and N-type channels. Second, although Cav1.2 and Cav2.2 share overlapping endoplasmic reticulum retention motifs in the proximal C terminus region, Cav1.2 channels seem to contain a second, downstream endoplasmic reticulum retention motif that does not seem to be conserved in Cav2.2 channels (Supplementary  Fig. 3 ). This redundancy might indicate a need to precisely control L-type channel expression for purposes such as calcium-dependent gene transcription 2 . Coexpression of the Cavβ subunit did not alter retention of the Cav1.2 C terminus in the endoplasmic reticulum, but it mediated a marked increase in cell surface and total protein expression of the full-length channel. Even though the I-II linker itself does not seem to contain an endoplasmic reticulum retention motif, binding of the Cavβ subunit to this region is critical, because the W440A mutant abolishes not only Cavβ binding to the channel, but also its ability to promote L-type channel membrane expression 25, 26 . All of these findings can be reconciled by a mechanism in which binding of the Cavβ subunit to the I-II linker sterically or perhaps allosterically interferes a r t I C l e S with the recognition of the C-terminal region as an endoplasmic reticulum retention motif in a properly folded channel protein.
Our data pinpoint RFP2 ligase as a key element in regulating the ubiquitination and expression of the channel. RFP2 is expressed in a number of tissues, such as the heart and the brain, that also express L-type channels 29 . Originally identified as a tumor suppressor 30 , RFP2 was only recently shown to be a ring finger ubiquitin ligase that is involved in ERAD 27 . As a result, there has been little if any information on the physiological role of its ligase activity. Our data showing that RFP2 regulates ubiquitination and membrane expression of Cav1.2 provide a glimpse into its function in the mammalian nervous system. Furthermore, this is one of only a few examples, such as CFTR, where a specific ubiquitin ligase has been linked to ion channel regulation at the level of the endoplasmic reticulum.
We could observe Cav1.2 ubiquitination only in the presence of MG132, which indicates that ubiquitinated channels are rapidly transported to the proteasome for degradation. This proteasomal transport seems to be mediated by derlin-1 and p97, two members of the ERAD complex. This is not without precedent in ion channels. For example, a CFTR deletion mutant that is misfolded retrotranslocates via Derlin-1, and similar observations have been reported for KCa3.1 and KCa3.2 mutants 21,31-33 . However, Cav1.2 channels differ in that the degradation process is regulated by an ancillary channel subunit, so that the channel can be recognized by the ERAD complex as a misfolded protein in the absence of Cavβ. Hence, the Cavβ subunit is a key determinant of channel stability, by virtue of its ability to divert Cav1.2, and possibly other types of HVA calcium channel, from the ERAD pathway to their appropriate locale in the plasma membrane.
Our data indicate that there is a basal level of Cav1.2 channel ubiquitination in both CAD cells and hippocampal neurons that can be unmasked by blocking proteasomal degradation. This suggests that in these cells there may be an excess of calcium channel α 1 subunits that could potentially be recruited upon increases in expression of the Cavβ subunit. There is evidence that Cavβ expression varies during neuronal development 34 , and is increased during pathophysiological conditions such as temporal lobe epilepsy 35 and during heart failure 36 , when an increase in Cavβ 2 subunits is mirrored by an increase in L-type channel density. Such findings fit with the idea that the cell surface density of calcium channels can be controlled by dynamic changes in ubiquitination that result from altered Cavβ expression.
Collectively, our findings reveal a bifurcation in the calcium channel export pathway from the endoplasmic reticulum, with a ubiquitin ligase and the Cavβ subunit defining alternate routes. Our data provide insights into the fundamental mechanisms of calcium channel sorting and trafficking, with potentially broad implications for a wide range of excitable cells.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website. a measure of total cellular channel expression. The ratio of cell surface to total cellular channel expression allowed comparisons between various conditions assayed from different batches of cells. In case of the CD4 constructs, the ratio of surface signal of luminescence to total signal of luminescence which represents the surface expression was normalized to the positive control (CD4-AA; Fig. 2c,d and Supplementary Fig. 4b ). As we used transient transfection that can cause different levels of expression and slight differences in the luminescence signal, this normalization allowed us to compare data from different cell batches.
electrophysiology. Whole-cell voltage-clamp recordings for tsA-201 cells and CAD neurons were performed 72 h after transfection. We used 7 µg of cDNA for transfection of tsA-201 cells (Cav1.2 or Cavα 2 -δ 1 (2 µg); GFP (0.5 µg) and WT-or DN-RFP2 (2 µg)). For CAD cells, Cav1.2 and Cavα 2 -δ 1 were omitted. Recordings were conducted with 20 mM barium as the charge carrier, using internal and external recording solutions as described 39 . Currents were elicited from a holding potential of −100 mV and depolarized from −70 to +50 mV with 10-mV increments. Data were collected from multiple batches of transfections with similar numbers of cells tested from the different groups (control, WT-RFP2 and DN-RFP2). For data analysis, peak currents and cell capacitance were measured and converted into current density.
Statistical analysis. Statistical analysis was conducted by t-tests or one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison tests. Statistical significance was set at P < 0.05, and all error bars represent s.e.m.
